Steve Innaimo
Chief Operating Officer at PORTAGE BIOTECH INC.
Net worth: - $ as of 31/03/2024
Profile
Presently, Steve Innaimo holds the position of VP-Project Management & Operations at Portage Biotech, Inc. In his past career he was Senior Director-Oncology Project Management at Bristol Myers Squibb Co. and Executive Director & Head-Project Management at Covance, Inc. Mr. Innaimo received an undergraduate degree and a graduate degree from the University of Connecticut.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PORTAGE BIOTECH INC
-.--% | 31/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Steve Innaimo active positions
| Companies | Position | Start |
|---|---|---|
| PORTAGE BIOTECH INC. | Chief Operating Officer | 08/01/2019 |
Former positions of Steve Innaimo
| Companies | Position | End |
|---|---|---|
| COVANCE INC. | Director/Board Member | 01/10/2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/03/2017 |
Training of Steve Innaimo
| University of Connecticut | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PORTAGE BIOTECH INC. | Health Technology |
| Private companies | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Steve Innaimo
